COVID-19

Clinical Resources

Materials for Providers

Alphabetical by Title

Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools

Checklist of links to key COVID-19 vaccination resources, including the date they were last revised.

Standing Orders for Administering 2025-2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer Nuvaxovid (Sanofi-Novavax) COVID-19 vaccine to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to children 6 months through 11 years, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, and IDSA are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

Materials for Vaccine Recipients

Alphabetical by Title

How mRNA COVID-19 Vaccines Work (CDC)

How Protein Subunit COVID-19 Vaccines Work (CDC)

CDC · FDA · State

ACIP Recommendations

Current Recommendations

Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR December 12, 2024 / 73(49);1118–1123
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025
MMWR: Early Release September 10, 2024, 73

Vaccine Information Statements

COVID-19 Vaccine VIS
Updated: January 31, 2025

FDA Package Inserts & Vaccine Fact Sheets (EUA)

COVID-19: Mnexspike Package Insert
Moderna
COVID-19: Nuvaxovid Package Insert
Novavax, Inc
COVID-19: Comirnaty Package Insert
Pfizer-BioNTech
COVID-19: Spikevax Package Insert
Moderna

Travel

All travelers should be up to date on routine vaccines. Depending on the destination, itinerary, and duration of travel, additional vaccines may be recommended.

CDC Resources

Travelers’ health information for healthcare providers

Partner Resources

Non-Governmental

The American Pharmacists Associationʼs resources and information on COVID 19, including vaccines, testing, education activities, webinars, practice resources, and advocacy opportunities.
Access WHOʼs COVID-19 resources, including public advice, Q&As, regulation and policy, news, vaccine manufacturers, and more.

More from Immunize.org

This page was updated on .